Header Logo

Mark Schmidt

Concepts (229)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Gastroenteritis
8
2024
25
3.320
Why?
Hepatitis C, Chronic
24
2024
64
3.320
Why?
Antiviral Agents
16
2024
94
1.580
Why?
Hepatitis B, Chronic
10
2023
27
1.520
Why?
Hepatitis C
8
2023
65
1.360
Why?
Delivery of Health Care, Integrated
5
2024
531
1.330
Why?
Rotavirus
4
2022
18
1.270
Why?
Liver Cirrhosis
11
2024
35
1.180
Why?
Caliciviridae Infections
2
2022
4
0.980
Why?
Cost of Illness
1
2024
92
0.890
Why?
Humans
54
2024
17611
0.860
Why?
United States
28
2024
3956
0.840
Why?
Herpes Zoster
1
2024
82
0.820
Why?
Carcinoma, Hepatocellular
5
2023
26
0.810
Why?
Health Care Costs
1
2024
228
0.800
Why?
Dementia
1
2024
106
0.790
Why?
Middle Aged
35
2024
7911
0.780
Why?
Child
14
2024
2474
0.770
Why?
Adult
34
2024
7598
0.740
Why?
Sustained Virologic Response
6
2023
17
0.720
Why?
Male
36
2024
10008
0.720
Why?
Young Adult
18
2024
2427
0.660
Why?
Epidemiological Monitoring
2
2018
25
0.660
Why?
Female
36
2024
12608
0.640
Why?
Rotavirus Vaccines
3
2024
50
0.620
Why?
Aged
25
2024
6095
0.600
Why?
Whooping Cough
2
2018
66
0.600
Why?
Infant
8
2024
1171
0.590
Why?
Cohort Studies
17
2024
2570
0.570
Why?
Adolescent
16
2024
3651
0.570
Why?
Liver Neoplasms
3
2023
40
0.540
Why?
Hepacivirus
10
2024
51
0.530
Why?
Child, Preschool
7
2024
1409
0.500
Why?
Tobacco Smoke Pollution
1
2015
34
0.480
Why?
Influenza Vaccines
2
2024
267
0.470
Why?
Patient Acceptance of Health Care
3
2023
382
0.470
Why?
Hepatitis B
3
2023
42
0.470
Why?
Immunization, Secondary
2
2013
55
0.470
Why?
Incidence
6
2024
1255
0.450
Why?
Rotavirus Infections
3
2022
31
0.430
Why?
Biomarkers
5
2017
301
0.400
Why?
Uterine Cervical Neoplasms
1
2013
119
0.400
Why?
Papillomavirus Vaccines
1
2013
113
0.400
Why?
Retrospective Studies
9
2024
2447
0.390
Why?
Coinfection
3
2023
30
0.390
Why?
Time Factors
10
2019
1086
0.380
Why?
Norovirus
2
2024
4
0.370
Why?
Feces
2
2022
80
0.350
Why?
Vaccination
4
2021
635
0.310
Why?
Delayed Diagnosis
2
2019
19
0.290
Why?
African Americans
5
2020
472
0.270
Why?
Risk Assessment
5
2023
1097
0.270
Why?
Diarrhea
2
2023
13
0.270
Why?
Influenza, Human
2
2024
263
0.250
Why?
Health Status
2
2020
298
0.250
Why?
Risk Factors
9
2020
3325
0.250
Why?
Hepatitis B virus
3
2023
20
0.250
Why?
History, 21st Century
1
2024
24
0.230
Why?
Aminoisobutyric Acids
1
2024
2
0.230
Why?
Cyclopropanes
1
2024
2
0.230
Why?
Lactams, Macrocyclic
1
2024
2
0.230
Why?
Leucine
1
2024
3
0.230
Why?
Benzimidazoles
1
2024
6
0.230
Why?
Proline
1
2024
5
0.230
Why?
Sulfonamides
1
2024
14
0.230
Why?
Acute Disease
1
2024
142
0.220
Why?
Herpesvirus 3, Human
1
2024
44
0.220
Why?
HIV Infections
2
2015
694
0.220
Why?
Chemical and Drug Induced Liver Injury
1
2023
10
0.210
Why?
Latent Tuberculosis
1
2023
10
0.210
Why?
Prospective Studies
7
2023
1267
0.210
Why?
Age Factors
5
2019
917
0.210
Why?
Quality of Life
3
2023
507
0.210
Why?
Ribavirin
2
2019
8
0.210
Why?
Liver
3
2017
32
0.210
Why?
Aspartate Aminotransferases
3
2020
13
0.200
Why?
Alanine Transaminase
3
2020
21
0.200
Why?
Aged, 80 and over
8
2020
1900
0.200
Why?
Diabetes Mellitus, Type 2
2
2019
748
0.190
Why?
Population Surveillance
1
2003
263
0.190
Why?
Tertiary Lymphoid Structures
1
2021
1
0.190
Why?
Health Services Accessibility
2
2021
289
0.190
Why?
Severity of Illness Index
4
2015
454
0.180
Why?
Follow-Up Studies
3
2019
1210
0.180
Why?
Cholagogues and Choleretics
1
2020
2
0.180
Why?
Liver Cirrhosis, Biliary
1
2020
2
0.180
Why?
Ursodeoxycholic Acid
1
2020
2
0.180
Why?
International Classification of Diseases
2
2017
85
0.170
Why?
Oregon
4
2024
171
0.170
Why?
Pancreatic Neoplasms
1
2021
67
0.170
Why?
Adenocarcinoma
1
2021
172
0.170
Why?
Coronavirus Infections
1
2020
49
0.170
Why?
Pneumonia, Viral
1
2020
56
0.160
Why?
Treatment Outcome
5
2024
1259
0.160
Why?
Logistic Models
3
2019
926
0.160
Why?
RNA, Viral
2
2019
64
0.160
Why?
Prevalence
5
2023
884
0.160
Why?
Stress, Psychological
1
2020
141
0.160
Why?
Virus Activation
1
2018
6
0.150
Why?
Feasibility Studies
1
2018
114
0.150
Why?
Patient Reported Outcome Measures
1
2018
48
0.150
Why?
Mental Health
2
2020
165
0.150
Why?
Data Mining
1
2017
17
0.150
Why?
Delivery of Health Care
2
2023
415
0.150
Why?
Diphtheria-Tetanus-acellular Pertussis Vaccines
1
2018
86
0.140
Why?
Decision Support Techniques
1
2017
88
0.140
Why?
Viral Load
1
2017
135
0.140
Why?
Case-Control Studies
2
2021
1115
0.140
Why?
Renal Insufficiency
1
2016
13
0.130
Why?
Gastroenterology
1
2016
18
0.130
Why?
Alcoholism
2
2017
347
0.130
Why?
Serum
1
2016
3
0.130
Why?
Data Collection
2
2014
256
0.130
Why?
Liver Failure
1
2015
1
0.130
Why?
Depression
2
2017
502
0.130
Why?
Referral and Consultation
1
2016
167
0.120
Why?
Pertussis Vaccine
1
2015
14
0.120
Why?
Vietnam Conflict
1
2014
1
0.120
Why?
Hepatitis A
1
2014
10
0.120
Why?
Hepatitis C Antibodies
1
2014
3
0.120
Why?
Molecular Diagnostic Techniques
1
2014
7
0.120
Why?
Cause of Death
3
2021
181
0.120
Why?
Off-Label Use
1
2013
14
0.110
Why?
European Continental Ancestry Group
3
2020
529
0.110
Why?
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
2013
32
0.110
Why?
Drug Utilization
1
2013
127
0.110
Why?
Veterans
1
2014
141
0.110
Why?
Asian Americans
3
2020
176
0.100
Why?
Electronic Health Records
2
2017
681
0.100
Why?
Platelet Count
3
2017
9
0.100
Why?
Smoking
1
2015
483
0.100
Why?
Hospitalization
3
2022
797
0.100
Why?
Health Maintenance Organizations
1
2013
417
0.100
Why?
Multivariate Analysis
3
2020
568
0.100
Why?
Biopsy
3
2015
74
0.090
Why?
Vaccines, Inactivated
1
2010
67
0.090
Why?
Meningitis, Meningococcal
1
2010
7
0.090
Why?
Adenovirus Infections, Human
1
2009
1
0.080
Why?
Adenoviruses, Human
1
2009
1
0.080
Why?
Substance Abuse, Intravenous
2
2014
33
0.080
Why?
Health Surveys
2
2020
260
0.080
Why?
Washington
2
2020
374
0.080
Why?
Fever
2
2023
55
0.070
Why?
Odds Ratio
2
2020
671
0.070
Why?
Proportional Hazards Models
2
2020
709
0.070
Why?
Comorbidity
2
2020
594
0.070
Why?
Social Support
2
2020
203
0.070
Why?
Hispanic Americans
2
2020
404
0.060
Why?
Critical Care
2
2020
71
0.060
Why?
Predictive Value of Tests
2
2017
351
0.060
Why?
Socioeconomic Factors
2
2019
630
0.060
Why?
Insurance, Health
2
2016
181
0.060
Why?
Disease Progression
2
2015
264
0.060
Why?
Sex Factors
2
2017
643
0.060
Why?
Pyrrolidines
1
2024
2
0.060
Why?
Pruritus
1
2023
3
0.060
Why?
Quinoxalines
1
2024
12
0.060
Why?
Fatigue
1
2023
34
0.060
Why?
Genotype
1
2024
227
0.060
Why?
Heterosexuality
1
2003
9
0.050
Why?
Homosexuality
1
2003
5
0.050
Why?
Michigan
1
2003
26
0.050
Why?
Disease Transmission, Infectious
1
2003
13
0.050
Why?
Sexual Partners
1
2003
37
0.050
Why?
Acquired Immunodeficiency Syndrome
1
2003
63
0.050
Why?
Women's Health
1
2003
200
0.050
Why?
Medical Records
2
2014
100
0.050
Why?
Internet
1
2023
231
0.050
Why?
Germinal Center
1
2021
1
0.050
Why?
Tumor Microenvironment
1
2021
2
0.050
Why?
Immunity, Humoral
1
2021
4
0.050
Why?
Survivorship
1
2021
9
0.050
Why?
Vaccines, Attenuated
1
2021
45
0.050
Why?
Liver Transplantation
1
2020
7
0.040
Why?
Unemployment
1
2020
11
0.040
Why?
Bilirubin
1
2020
30
0.040
Why?
Oceanic Ancestry Group
1
2020
33
0.040
Why?
Betacoronavirus
1
2020
35
0.040
Why?
Length of Stay
1
2020
181
0.040
Why?
Survival Rate
1
2020
260
0.040
Why?
Ambulatory Care
1
2021
244
0.040
Why?
Intensive Care Units
1
2020
104
0.040
Why?
Interferons
1
2019
5
0.040
Why?
Drug Therapy, Combination
1
2019
114
0.040
Why?
Public Health Surveillance
1
2019
42
0.040
Why?
Healthcare Disparities
1
2020
201
0.040
Why?
Observational Studies as Topic
1
2018
47
0.040
Why?
Clinical Enzyme Tests
1
2017
1
0.040
Why?
Blood Platelets
1
2017
2
0.040
Why?
Pandemics
1
2020
287
0.040
Why?
Glycated Hemoglobin A
1
2019
216
0.040
Why?
Fibrosis
1
2017
7
0.040
Why?
Kaplan-Meier Estimate
1
2017
129
0.040
Why?
Sex Distribution
1
2017
190
0.040
Why?
Age Distribution
1
2017
246
0.030
Why?
Blood Glucose
1
2019
341
0.030
Why?
Reproducibility of Results
1
2017
381
0.030
Why?
Medicine
1
2016
22
0.030
Why?
Mamastrovirus
1
2016
1
0.030
Why?
Astroviridae Infections
1
2016
1
0.030
Why?
Sapovirus
1
2016
1
0.030
Why?
Treatment Failure
1
2016
35
0.030
Why?
Prognosis
1
2017
606
0.030
Why?
Disease Management
1
2016
135
0.030
Why?
Continuity of Patient Care
1
2016
105
0.030
Why?
Surveys and Questionnaires
1
2020
1309
0.030
Why?
Medicare
1
2016
202
0.030
Why?
Survival Analysis
1
2015
215
0.030
Why?
Medicaid
1
2016
186
0.030
Why?
Hepatitis A Antibodies
1
2014
2
0.030
Why?
Hepatitis B Antibodies
1
2014
6
0.030
Why?
Hepatitis B Surface Antigens
1
2014
12
0.030
Why?
Anti-Retroviral Agents
1
2015
80
0.030
Why?
Hepatitis A Vaccines
1
2014
14
0.030
Why?
Hepatitis B Vaccines
1
2014
43
0.030
Why?
Pathology
1
2014
4
0.030
Why?
Alcohol Drinking
1
2017
368
0.030
Why?
California
1
2020
2284
0.030
Why?
Sensitivity and Specificity
1
2014
304
0.030
Why?
Longitudinal Studies
1
2016
710
0.030
Why?
Infant, Newborn
1
2016
844
0.030
Why?
Primary Health Care
1
2019
766
0.030
Why?
Ethnic Groups
1
2016
485
0.030
Why?
Research Design
1
2014
374
0.020
Why?
Diabetes Mellitus
1
2015
487
0.020
Why?
Substance-Related Disorders
1
2014
434
0.020
Why?
Serotyping
1
2009
3
0.020
Why?
Oxygen
1
2009
16
0.020
Why?
Cross Infection
1
2009
27
0.020
Why?
Concepts (229)
Explore
_
Co-Authors (9)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_
-->

© 2025 Kaiser Permanente